Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Oct-Dec;17(4):247-50.
doi: 10.1007/BF03190155.

Hemodynamic effects on hepatic blood flow of a selective beta 2-adrenoceptor agonist, clenbuterol, in rat

Affiliations

Hemodynamic effects on hepatic blood flow of a selective beta 2-adrenoceptor agonist, clenbuterol, in rat

L D Masnatta et al. Eur J Drug Metab Pharmacokinet. 1992 Oct-Dec.

Abstract

Acute clenbuterol administration (50 micrograms/kg, i.v.) to anesthetized normotensive rats, produce a marked reduction in the mean blood pressure, (MBP), about 58 mm Hg. Indocyanine Green clearance analysis (control, 1.83 +/- 0.15: clenbuterol, 1.10 +/- 0.20 ml/min/100 g, P < 0.05) showed that the action in the hepatic vascular bed is opposite to its systemic vasodilator effects. The hepatic blood flow (HBF) appears significantly reduced (control, 8.24 +/- 0.35: clenbuterol, 3.83 +/- 0.71 ml/min/100 g, P < 0.05) whereas the hepatic uptake and excretion proceedings were apparently not affected (control hepatic extraction coefficient, 0.225 +/- 0.024: clenbuterol, 0.300 +/- 0.04, NS). These findings show that a marked reduction in HBF follows systemic vasodilator effects produced by clenbuterol.

PubMed Disclaimer

Similar articles

References

    1. Br J Pharmacol. 1978 Mar;62(3):376P-377P - PubMed
    1. Pflugers Arch. 1981 Oct;391(4):353-4 - PubMed
    1. Hepatology. 1984 Sep-Oct;4(5):927-32 - PubMed
    1. J Physiol. 1951 Dec 28;115(4):430-41 - PubMed
    1. Br J Pharmacol. 1972 Feb;44(2):177-84 - PubMed

LinkOut - more resources